As the global economy recovers in 2021 and the supply of the industrial chain improves, the Injection Peptide Drug market will undergo major changes. According to the latest research, the market size of the Injection Peptide Drug industry in 2021 will increase by USD million compared to 2020, with a growth rate of %.
The global Injection Peptide Drug industry report provides top-notch qualitative and quantitative information including: Market size (2017-2021 value and 2022 forecast). The report also contains descriptions of key players, including key financial indicators and market competitive pressure analysis.
The report also assesses key opportunities in the market and outlines the factors that are and will drive the growth of the industry. Taking into account previous growth patterns, growth drivers, and current and future trends, we also forecast the overall growth of the global Injection Peptide Drug market during the next few years. The global Injection Peptide Drug market size will reach USD million in 2028, growing at a CAGR of % during the analysis period.
This report presents a comprehensive overview, market shares, and growth opportunities of Injection Peptide Drug market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Intravenous Injection
Subcutaneous Injection
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Cancer
Metabolic Disorders
Central Nervous System
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
AbbVie
Ipsen
Ferring
Merck
The Medicines
J & J
Table of Content
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Injection Peptide Drug Market Size 2017-2028
2.1.2 Injection Peptide Drug Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Injection Peptide Drug Segment by Type
2.2.1 Intravenous Injection
2.2.2 Subcutaneous Injection
2.3 Injection Peptide Drug Market Size by Type
2.3.1 Injection Peptide Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Injection Peptide Drug Market Size Market Share by Type (2017-2022)
2.4 Injection Peptide Drug Segment by Application
2.4.1 Cancer
2.4.2 Metabolic Disorders
2.4.3 Central Nervous System
2.4.4 Other
2.5 Injection Peptide Drug Market Size by Application
2.5.1 Injection Peptide Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Injection Peptide Drug Market Size Market Share by Application (2017-2022)
3 Injection Peptide Drug Market Size by Player
3.1 Injection Peptide Drug Market Size Market Share by Players
3.1.1 Global Injection Peptide Drug Revenue by Players (2020-2022)
3.1.2 Global Injection Peptide Drug Revenue Market Share by Players (2020-2022)
3.2 Global Injection Peptide Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Injection Peptide Drug by Regions
4.1 Injection Peptide Drug Market Size by Regions (2017-2022)
4.2 Americas Injection Peptide Drug Market Size Growth (2017-2022)
4.3 APAC Injection Peptide Drug Market Size Growth (2017-2022)
4.4 Europe Injection Peptide Drug Market Size Growth (2017-2022)
4.5 Middle East & Africa Injection Peptide Drug Market Size Growth (2017-2022)
5 Americas
5.1 Americas Injection Peptide Drug Market Size by Country (2017-2022)
5.2 Americas Injection Peptide Drug Market Size by Type (2017-2022)
5.3 Americas Injection Peptide Drug Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Injection Peptide Drug Market Size by Region (2017-2022)
6.2 APAC Injection Peptide Drug Market Size by Type (2017-2022)
6.3 APAC Injection Peptide Drug Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Injection Peptide Drug by Country (2017-2022)
7.2 Europe Injection Peptide Drug Market Size by Type (2017-2022)
7.3 Europe Injection Peptide Drug Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Injection Peptide Drug by Region (2017-2022)
8.2 Middle East & Africa Injection Peptide Drug Market Size by Type (2017-2022)
8.3 Middle East & Africa Injection Peptide Drug Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Injection Peptide Drug Market Forecast
10.1 Global Injection Peptide Drug Forecast by Regions (2023-2028)
10.1.1 Global Injection Peptide Drug Forecast by Regions (2023-2028)
10.1.2 Americas Injection Peptide Drug Forecast
10.1.3 APAC Injection Peptide Drug Forecast
10.1.4 Europe Injection Peptide Drug Forecast
10.1.5 Middle East & Africa Injection Peptide Drug Forecast
10.2 Americas Injection Peptide Drug Forecast by Country (2023-2028)
10.2.1 United States Injection Peptide Drug Market Forecast
10.2.2 Canada Injection Peptide Drug Market Forecast
10.2.3 Mexico Injection Peptide Drug Market Forecast
10.2.4 Brazil Injection Peptide Drug Market Forecast
10.3 APAC Injection Peptide Drug Forecast by Region (2023-2028)
10.3.1 China Injection Peptide Drug Market Forecast
10.3.2 Japan Injection Peptide Drug Market Forecast
10.3.3 Korea Injection Peptide Drug Market Forecast
10.3.4 Southeast Asia Injection Peptide Drug Market Forecast
10.3.5 India Injection Peptide Drug Market Forecast
10.3.6 Australia Injection Peptide Drug Market Forecast
10.4 Europe Injection Peptide Drug Forecast by Country (2023-2028)
10.4.1 Germany Injection Peptide Drug Market Forecast
10.4.2 France Injection Peptide Drug Market Forecast
10.4.3 UK Injection Peptide Drug Market Forecast
10.4.4 Italy Injection Peptide Drug Market Forecast
10.4.5 Russia Injection Peptide Drug Market Forecast
10.5 Middle East & Africa Injection Peptide Drug Forecast by Region (2023-2028)
10.5.1 Egypt Injection Peptide Drug Market Forecast
10.5.2 South Africa Injection Peptide Drug Market Forecast
10.5.3 Israel Injection Peptide Drug Market Forecast
10.5.4 Turkey Injection Peptide Drug Market Forecast
10.5.5 GCC Countries Injection Peptide Drug Market Forecast
10.6 Global Injection Peptide Drug Forecast by Type (2023-2028)
10.7 Global Injection Peptide Drug Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Injection Peptide Drug Product Offered
11.1.3 Sanofi Injection Peptide Drug Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Teva
11.2.1 Teva Company Information
11.2.2 Teva Injection Peptide Drug Product Offered
11.2.3 Teva Injection Peptide Drug Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Teva Main Business Overview
11.2.5 Teva Latest Developments
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Information
11.3.2 Novo Nordisk Injection Peptide Drug Product Offered
11.3.3 Novo Nordisk Injection Peptide Drug Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Novo Nordisk Main Business Overview
11.3.5 Novo Nordisk Latest Developments
11.4 Takeda
11.4.1 Takeda Company Information
11.4.2 Takeda Injection Peptide Drug Product Offered
11.4.3 Takeda Injection Peptide Drug Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Takeda Main Business Overview
11.4.5 Takeda Latest Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Company Information
11.5.2 Eli Lilly Injection Peptide Drug Product Offered
11.5.3 Eli Lilly Injection Peptide Drug Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Eli Lilly Main Business Overview
11.5.5 Eli Lilly Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Injection Peptide Drug Product Offered
11.6.3 AstraZeneca Injection Peptide Drug Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Injection Peptide Drug Product Offered
11.7.3 Novartis Injection Peptide Drug Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Novartis Main Business Overview
11.7.5 Novartis Latest Developments
11.8 AbbVie
11.8.1 AbbVie Company Information
11.8.2 AbbVie Injection Peptide Drug Product Offered
11.8.3 AbbVie Injection Peptide Drug Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 AbbVie Main Business Overview
11.8.5 AbbVie Latest Developments
11.9 Ipsen
11.9.1 Ipsen Company Information
11.9.2 Ipsen Injection Peptide Drug Product Offered
11.9.3 Ipsen Injection Peptide Drug Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Ipsen Main Business Overview
11.9.5 Ipsen Latest Developments
11.10 Ferring
11.10.1 Ferring Company Information
11.10.2 Ferring Injection Peptide Drug Product Offered
11.10.3 Ferring Injection Peptide Drug Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Ferring Main Business Overview
11.10.5 Ferring Latest Developments
11.11 Merck
11.11.1 Merck Company Information
11.11.2 Merck Injection Peptide Drug Product Offered
11.11.3 Merck Injection Peptide Drug Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Merck Main Business Overview
11.11.5 Merck Latest Developments
11.12 The Medicines
11.12.1 The Medicines Company Information
11.12.2 The Medicines Injection Peptide Drug Product Offered
11.12.3 The Medicines Injection Peptide Drug Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 The Medicines Main Business Overview
11.12.5 The Medicines Latest Developments
11.13 J & J
11.13.1 J & J Company Information
11.13.2 J & J Injection Peptide Drug Product Offered
11.13.3 J & J Injection Peptide Drug Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 J & J Main Business Overview
11.13.5 J & J Latest Developments
12 Research Findings and Conclusion
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
AbbVie
Ipsen
Ferring
Merck
The Medicines
J & J
*If Applicable.